# Neogen Corp (NEOG)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/neogen-corp/ JSON: https://steadybase.io/company/neogen-corp.json Checked Nov 10, 2026. Latest filing read: Oct 20, 2026.

## Company

- Legal name: NEOGEN CORP
- Ticker: NEOG (Nasdaq)
- SEC CIK: 0000711377
- Industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Headquarters: Lansing, MI
- Fiscal year ends: May 31
- SEC filer category: Large accelerated filer
- Website: neogen.com
- LinkedIn: https://www.linkedin.com/company/neogen-europe
- Next earnings date: Jan 5, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $870.4M for the fiscal year ended May 31, 2026 (10-K filed Jul 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/0001193125-26-326092-index.html
- Operating income: -$21.6M for the fiscal year ended May 31, 2026 (10-K filed Jul 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/0001193125-26-326092-index.html
- Net income: -$7.9M for the fiscal year ended May 31, 2026 (10-K filed Jul 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/0001193125-26-326092-index.html
- SG&A: $411.7M for the fiscal year ended May 31, 2026 (10-K filed Jul 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/0001193125-26-326092-index.html
- Employees: 2,636 as of May 31, 2026, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Shares outstanding: 218,306,034 as of Aug 31, 2026 (10-Q filed Oct 7, 2026). Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526416954/0001193125-26-416954-index.html
- Auditor: Bdo Usa, P.C., Grand Rapids, MI, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm

## Business

Neogen Corporation and its subsidiaries develop, manufacture and market a diverse line of products and services dedicated to food and animal safety., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. We also have products to determine food quality and nutritional components.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| May 31, 2026 | $870.4M | -$21.6M | -$7.9M | $411.7M |
| May 31, 2025 | $894.7M | -$1.1B | -$1.1B | $402.0M |
| May 31, 2024 | $924.2M | $58.6M | -$9.4M | $382.8M |
| May 31, 2023 | $822.4M | $37.5M | -$22.9M | $342.4M |
| May 31, 2022 | $527.2M | $58.6M | $48.3M | $167.3M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/neogen-corp.json

## Officers and directors

- Mikheal Nassif, CEO. Source: Form 4 filed Aug 20, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000019/0000711377-26-000019-index.htm
- John Edward Adent, Former CEO. Source: Form 4 filed Oct 28, 2025, https://www.sec.gov/Archives/edgar/data/711377/000071137725000062/0000711377-25-000062-index.htm
- Richard Bryan Riggsbee, CFO. Source: Form 4 filed Aug 14, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000015/0000711377-26-000015-index.htm
- R. Bryan Riggsbee, Chief Financial Officer. LinkedIn: https://www.linkedin.com/in/bryan-riggsbee-47b2968. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- David H. Naemura, Former CFO. Source: Form 4 filed Dec 2, 2025, https://www.sec.gov/Archives/edgar/data/711377/000071137725000077/0000711377-25-000077-index.htm
- Douglas Edward Jones, Former COO. Source: Form 4 filed Oct 28, 2025, https://www.sec.gov/Archives/edgar/data/711377/000071137725000063/0000711377-25-000063-index.htm
- Jeremy Yarwood, Chief Scientific Officer. Source: Form 4 filed Nov 4, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000045/0000711377-26-000045-index.htm
- Joe B. Freels, Chief Commercial Officer. Source: Form 4 filed Nov 3, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000044/0000711377-26-000044-index.htm
- Kevin M. Burke, Chief HR Officer. Source: Form 3 filed Oct 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000040/0000711377-26-000040-index.htm
- John Patrick Moylan, Chief Accounting Officer. Source: Form 4 filed Aug 20, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000020/0000711377-26-000020-index.htm
- Jennifer Evans Stacey, Chief Legal Officer. Source: Form 4 filed Aug 14, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000016/0000711377-26-000016-index.htm
- John P. Moylan, Chief Accounting Officer. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Amy M. Rocklin, Former Chief Legal Officer. LinkedIn: https://linkedin.com/in/amy-rocklin-08989510. Source: Form 4 filed May 19, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000010/0000711377-26-000010-index.htm
- James C. Borel, Chairman of the Board of Directors. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Tamara A. Ranalli, Senior Vice President. LinkedIn: https://linkedin.com/in/tamararanalli. Source: Form 4 filed Aug 14, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000017/0000711377-26-000017-index.htm
- Gregory S. Hastings, VP, Animal Health. Source: Form 4 filed Oct 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000043/0000711377-26-000043-index.htm
- James A. Walter, SVP of Manufacturing. Source: Form 3 filed Oct 21, 2026, https://www.sec.gov/Archives/edgar/data/711377/000071137726000032/0000711377-26-000032-index.htm
- Aashima Gupta, Director. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Andrea F. Wainer, Director. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Avi Pelossof, Director. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Jeffrey D. Capello, Director. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Raphael A. Rodriguez, Director. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Ronald D. Green, Ph.D, Director. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Thierry Bernard, Director. Source: 10-K filed Jul 30, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- Jim Borel, Board member (per proxy). Source: DEF 14A filed Aug 21, 2026, https://www.sec.gov/Archives/edgar/data/711377/000119312526360742/neog-20260821.htm

## Recent 8-K events

- Nov 4, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526447166/neog-20261104.htm
- Oct 7, 2026: Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526416247/neog-20261001.htm
- Oct 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526415544/neog-20261006.htm
- Aug 7, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526340216/neog-20260803.htm
- Jul 30, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526324860/neog-20260730.htm
- Apr 20, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526162667/neog-20260420.htm
- Apr 9, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526148851/neog-20260409.htm
- Mar 30, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526130470/neog-20260330.htm
- Jan 8, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526006990/neog-20260108.htm
- Oct 30, 2025: Item 5.02, Departure or appointment of directors or officers; compensation; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/711377/000119312525257565/neog-20251030.htm

## Insider trades (Form 4)

- Nov 4, 2026: Jeremy Yarwood (Chief Scientific Officer) sold 9,051 shares, about $114,676. Source: https://www.sec.gov/Archives/edgar/data/711377/000071137726000045/0000711377-26-000045-index.htm
- Oct 9, 2026: Mikheal Nassif (CEO) bought 505 shares, about $6,035. Source: https://www.sec.gov/Archives/edgar/data/711377/000071137726000029/0000711377-26-000029-index.htm
- Aug 4, 2026: Mikheal Nassif (CEO) bought 370 shares, about $4,370. Source: https://www.sec.gov/Archives/edgar/data/711377/000071137726000013/0000711377-26-000013-index.htm
- Feb 17, 2026: Mikheal Nassif (CEO) bought 23 shares, about $252. Source: https://www.sec.gov/Archives/edgar/data/711377/000071137726000006/0000711377-26-000006-index.htm
- Feb 2, 2026: Mikheal Nassif (CEO) bought 49 shares, about $487. Source: https://www.sec.gov/Archives/edgar/data/711377/000071137726000005/0000711377-26-000005-index.htm
- Jan 16, 2026: Mikheal Nassif (CEO) bought 137 shares, about $1,278. Source: https://www.sec.gov/Archives/edgar/data/711377/000071137726000001/0000711377-26-000001-index.htm
- Nov 3, 2025: Mikheal Nassif (CEO) bought 177 shares, about $1,106. Source: https://www.sec.gov/Archives/edgar/data/711377/000071137725000076/0000711377-25-000076-index.htm

## What management said

- "As we entered fiscal year 2027, our focus shifted from strengthening fundamentals to scaling them to drive more consistent execution, improved customer outcomes and profitable growth" Mike Nassif, Neogen’s President and Chief Executive Officer (8-K filed Oct 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/711377/000119312526415544/neog-ex99_1.htm

## Latest filings

- 8-K filed Oct 7, 2026: https://www.sec.gov/Archives/edgar/data/711377/000119312526416247/neog-20261001.htm
- 10-K filed Jul 30, 2026: https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm
- 10-Q filed Oct 7, 2026: https://www.sec.gov/Archives/edgar/data/711377/000119312526416954/neog-20260831.htm
- DEF 14A filed Aug 21, 2026: https://www.sec.gov/Archives/edgar/data/711377/000119312526360742/neog-20260821.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/